Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

Published:2019 Issue:16 Volume:9 Page:4678-4687
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Lu Jia-Cheng,Zeng Hai-Ying,Sun Qi-Man,Meng Qing-Nan,Huang Xiao-Yong,Zhang Peng-Fei,Yang Xuan,Peng Rui,Gao Chao,Wei Chuan-Yuan,Shen Ying-Hao,Cai Jia-Bing,Dong Rui-Zhao,Shi Ying-Hong,Sun Hui-Chuan,Shi Yujiang G.,Zhou Jian,Fan Jia,Ke Ai-Wu,Yang Liu-Xiao,Shi Guo-Ming

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06

2. Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer;International Immunopharmacology;2024-05

3. Current Status and Progress of Systemic and Local Therapy for Intrahepatic Cholangiocarcinoma;Advances in Clinical Medicine;2024

4. Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes;Exploration of Targeted Anti-tumor Therapy;2023-12-28

5. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review);International Journal of Oncology;2023-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP